The pathogenic mechanisms underlying double-expressor diffuse large B-cell lymphoma (DE-DLBCL), specifically related to the myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2), are not yet fully understood. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.